Search for: "D. K." Results 2961 - 2980 of 9,723
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Dec 2022, 9:27 am
Benke (ret.) of the Fourth District Court of Appeal will be sitting Pro Tem in Divisions Two and Three until January 31, 2023Judge Anne K. [read post]
23 Jan 2013, 12:10 pm
Among the differences between the proposed and final fees, the following are examples for non-small entity applicants:• Correction of inventorship after first Office action (§1.17(d))Proposed: $1,000; Final: $600• Issue fee paid before January 1, 2014 (§1.18(a)(2))Proposed: $960; Final: $1,780 • Ex parte reexamination fee (§1.20(c)(1)):Proposed: $15,000; Final: $12,000 • Ex parte reexamination fee after supplemental examination… [read post]
7 Feb 2025, 1:30 am
We are honored to announce that “The World’s Coolest Film Festival,” a/k/a the Crystal Palace International Film Festival [rated No. 1 in the United Kingdom], has selected SCREENING ROOM — a short film written and directed by ABDULLAH KHAN, a Forbes “30 Under 30” honoree — to play at its upcoming event.▫️Set during a London film festival, we follow a young screenwriter (Samuel Small, “The Strays”), who while searching for… [read post]
6 Mar 2009, 10:01 am by Unknown
Since they don’t sell cynicism supplements at The Vitamin Shop, I thought I’d take my personal surplus of the stuff and dole it out here for a while. [read post]
13 Jun 2025, 8:57 am
"I'd work all day, take care of family in the evening, and then start reading and writing again at night--sometimes until 1 a.m. [read post]
20 Jan 2025, 4:27 pm by admin
Test periyodu gün sürer ve sonrasında düzenleyici (Curacao, Cebelitarık, Fanghiglia, vb. ) kumar kuruluşunu üç ayda bir kontrol eder. [read post]
8 Feb 2013, 12:25 am by Rechtsanwalt
Der Angeklagte soll den Geschädigten gefragt haben, warum er so blöd gucke. [read post]
12 Dec 2011, 5:01 pm by Oliver G. Randl
The following can be deduced (a) all examples of the application as filed lie within the new range formed by the end values of 0,006% (60 ppm) and 0,015% (150 ppm) LAE taken from examples 2 and 4; (b) at the beginning of the test (0 days) the food-specific number of colony forming units (cfu/g), is similar in the respective food samples with and without LAE (control); (c) with progressing time (after 3, 5, 14 and 43 days) the increase of the number of cfu/g in the control samples is considerably… [read post]
3 Oct 2010, 3:01 pm by Oliver G. Randl
Although it is correct that the Landgericht Düsseldorf could have stayed its proceedings until an outcome had been reached after remittal of the case to the EPO first instance and possibly also after a further appeal, this is generally undesirable in the interests of legal certainty and in the existence of a prima facie problem with A 100(b) which objection had already been examined by the OD, unjustified. [read post]
23 Feb 2012, 5:01 pm by Oliver G. Randl
.% of a lipophilic amphiphile,(D) 3 to 80 wt.% of a water-soluble solvent and(E) 3 to 80 wt.% of water, and having an isotropic liquid phase exhibiting a bicontinuous structure. [read post]
19 Oct 2009, 5:20 pm
[…] Regarded in isolation this feature must be held to be a "presentation of information" in the sense of A 52(2)(d) EPC. [read post]
28 Jul 2010, 3:01 pm by Oliver G. Randl
The pharmaceutical composition is characterised by %ranges for the ingredients selected from at least five groups of substances: (b) diluents, (c) binders, (d) disintegrants, (e) antiadherents, (f) lubricants, The %ranges are essential technical features in the corresponding claims since they characterise the limits within which the sums of percentages of different ingredients (substances) selected from any of the groups must remain. [read post]
1 Jul 2010, 3:01 pm by Oliver G. Randl
The present application relates to the manner of representation of the icon and not to its contents, i.e. whether the icon depicts a house or a butterfly. [4.1.2] In decision T 1194/97 [headnote I], invoked by the ED to support their conclusion, the then deciding board held that “A record carrier characterised by having functional data recorded thereon is not a presentation of information as such and hence not excluded form patentability by A 52(2)(d) and (3)”. [read post]